{
  "id": "prt_959338603001T7U8LOk1meeifD",
  "type": "text",
  "text": "still not multilingual:\n\nCriteria Engine\nPas CDC, NASEM, ESC, WHO diagnostische criteria toe voor definitieve bepaling\n\nME/CVS Criteria (CDC/NASEM 2015)\nVereist substantiële vermoeidheid, PEM, niet-verkwikkende slaap, EN cognitieve stoornissen OF orthostatische intolerantie\n\n\nSubstantial reduction or impairment in activity levels that persists for ≥6 months\n\nPost-exertional malaise (PEM) present\n\nUnrefreshing sleep\n\nCognitive impairment (brain fog)\n\nOrthostatic intolerance OR autonomic dysfunction\nLong COVID Criteria (WHO/NASEM 2024)\nPost-acute gevolgen van SARS-CoV-2 infectie met persistente multi-systeem symptomen\n\n\nConfirmed or probable SARS-CoV-2 infection\n\nSymptoms persist ≥3 months from acute illness\n\nMulti-system symptoms affecting daily functioning\n\nSymptoms not explained by alternative diagnosis\nPOTS Criteria (ESC 2018/AAS-EFAS 2021)\nHartslagtoename ≥30 spm binnen 10 minuten van staan, met symptomen maar zonder orthostatische hypotensie\n\n\nHeart rate increase ≥30 bpm within 10 minutes of standing\n\nSustained heart rate ≥120 bpm while standing\n\nOrthostatic symptoms (dizziness, palpitations, fatigue)\n\nSymptoms present for ≥3 months\n\nAbsence of orthostatic hypotension",
  "messageID": "msg_959338602001fhNp46i4Wu3uZ5",
  "sessionID": "ses_6a7af0913ffePKeafEVjU8Zw0Y"
}